KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Elevance Health (ELV) Asset Writedowns and Impairment (2016 - 2025)

Elevance Health (ELV) has disclosed Asset Writedowns and Impairment for 14 consecutive years, with $38.0 million as the latest value for Q4 2025.

Quarterly Asset Writedowns and Impairment changed N/A to $38.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $45.0 million through Dec 2025, down 43.75% year-over-year, with the annual reading at $108.0 million for FY2025, 4.85% up from the prior year.
Asset Writedowns and Impairment for Q4 2025 was $38.0 million at Elevance Health, up from $7.0 million in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $73.0 million in Q4 2021, with the low at $7.0 million in Q4 2022.
Average Asset Writedowns and Impairment over 3 years is $39.3 million, with a median of $38.0 million recorded in 2025.
The sharpest move saw Asset Writedowns and Impairment soared 2333.33% in 2021, then crashed 90.41% in 2022.
Over 3 years, Asset Writedowns and Impairment stood at $73.0 million in 2021, then plummeted by 90.41% to $7.0 million in 2022, then surged by 442.86% to $38.0 million in 2025.
According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $38.0 million, $7.0 million, and $73.0 million for Q4 2025, Q4 2022, and Q4 2021 respectively.